Aducanumab Q & A
Experts from the University of Wisconsin School of Medicine and Public Health recently shared insight and answered audience questions about aducanumab (marketed as Aduhelm) via a Facebook Live presentation. Learn how this new treatment for Alzheimer’s disease targets amyloid protein buildup, possible side effects of taking the drug and the issue of equal representation in …